Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes
暂无分享,去创建一个
H Buerger | K L Schäfer | C Poremba | R. Simon | C. Poremba | F. Otterbach | B. Dockhorn‐Dworniczak | W. Boecker | R. Diallo | H. Buerger | C. Brinkschmidt | W Boecker | R Simon | K. Schäfer | B Dockhorn-Dworniczak | F Otterbach | R Diallo | C Brinkschmidt | R. Simon
[1] G. Peters,et al. Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. , 1990, European journal of cancer.
[2] J Isola,et al. Molecular cytogenetics of primary breast cancer by CGH , 1998, Genes, chromosomes & cancer.
[3] F. Lampert,et al. COMPARATIVE GENOMIC HYBRIDIZATION (CGH) ANALYSIS OF NEUROBLASTOMAS—AN IMPORTANT METHODOLOGICAL APPROACH IN PAEDIATRIC TUMOUR PATHOLOGY , 1997, The Journal of pathology.
[4] B. Dutrillaux,et al. Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. , 1990, Cancer genetics and cytogenetics.
[5] M. J. van de Vijver,et al. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. , 1992, Cancer research.
[6] A. Tanigami,et al. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. , 1990, Cancer research.
[7] Y. Nakamura,et al. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. , 1994, Cancer research.
[8] C. Theillet,et al. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. , 1997, Cancer research.
[9] F. Speleman,et al. Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer , 1997, Virchows Archiv.
[10] C. Larsson,et al. Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. , 1993, Cancer research.
[11] J Isola,et al. Genetic alterations in lobular breast cancer by comparative genomic hybridization , 1997, International journal of cancer.
[12] P. Devilee,et al. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer , 1994, Genes, chromosomes & cancer.
[13] A. Zetterberg,et al. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. , 1995, Cancer research.
[14] C. Poremba,et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast—evidence of multiple genetic pathways , 1999, The Journal of pathology.
[15] S. Hirohashi,et al. Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization. , 1997, The American journal of pathology.
[16] R. Simon,et al. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer , 1998 .
[17] P. Carroll,et al. Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. , 1994, The American journal of pathology.
[18] G. Peters,et al. Chromosome 11q13 abnormalities in human breast cancer. , 1993, Cancer surveys.
[19] M. J. van de Vijver,et al. Ductal carcinoma in situ: a proposal for a new classification. , 1994, Seminars in diagnostic pathology.
[20] M. Stratton. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.
[21] J. Overgaard,et al. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. , 1998, Cancer research.
[22] J. Berg,et al. TUMORS of the breast. I. , 1954, Medical times.
[23] S. Hilsenbeck,et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. , 1995, The American journal of pathology.
[24] P. V. van Diest,et al. Genetic analysis of 53 lymph node‐negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors , 1998, The Journal of pathology.
[25] N. Sneige,et al. Mucocelelike tumor of the breast associated with atypical ductal hyperplasia or mucinous carcinoma. A clinicopathologic study of seven cases. , 1991, Archives of pathology & laboratory medicine.
[26] S. Hirohashi,et al. Detection of allele loss on chromosome 16q in DNA isolated from fine needle aspiration specimens of breast tumors. A simulation study using surgically resected specimens. , 1996, Acta cytologica.